Lisdexamfetamine, marketed as Vyvanse, is a scheduled drug approved in the country for treating Attention-Deficit/Hyperactivity Dysfunction in children and people. This functions as a prodrug, meaning https://vyvanseincanada556284.blog-center.com/61949452/vyvanse-in-this-country-a-detailed-overview